Kenya

Kenya is rapidly emerging as the pharmaceutical manufacturing hub of East Africa, driven by a robust National Local Manufacturing Strategy aimed at achieving regional self-sufficiency.

As a gateway to the East African Community (EAC) and AfCFTA markets, the country offers a strategic landscape for life sciences investment and high-growth biotechnology research.

Kenya is best known for its pioneering healthcare innovation, particularly in digital health and mHealth (mobile health), where AI-powered diagnostics and telemedicine are bridging critical care gaps.

The medical device market is expanding through local production of essential technologies, supported by favorable regulatory reforms and streamlined approval timelines.

Clinical trials in Kenya benefit from a diverse patient population and world-class academic research institutions like the Kenya Medical Research Institute (KEMRI).

International partners increasingly view Nairobi as a "Silicon Savannah" for biopharma and health tech, fostering a vibrant ecosystem for startups and established multinationals.

With a commitment to Universal Health Coverage (UHC), the government continues to incentivize supply chain localization and precision medicine initiatives.

This dynamic environment positions Kenya as a premier destination for global stakeholders seeking to scale life sciences solutions across the African continent.